Sage Therapeutics Inc (SAGE) Testing Investors’ Patience Right Now
Currently, there are 61.17M common shares owned by the public and among those 53.88M shares have been available to trade. The company’s stock has a 5-day price change of 22.15% and 17.74% over the past three months. SAGE shares are trading 38.12% year to date (YTD), with the 12-month market performance down to -70.47% lower. […]
